These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. [Alterations of serum lipoprotein (a) levels in continuous ambulatory peritoneal dialysis (CAPD) patients]. Tanaka S Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):746-51. PubMed ID: 8084076 [TBL] [Abstract][Full Text] [Related]
29. Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis. Attman PO; Samuelsson OG; Moberly J; Johansson AC; Ljungman S; Weiss LG; Knight-Gibson C; Alaupovic P Kidney Int; 1999 Apr; 55(4):1536-42. PubMed ID: 10201020 [TBL] [Abstract][Full Text] [Related]
30. Fall of cholesterol with time on dialysis: impact on atherogenicity. Lapuz M; Avram MM; Lustig A; Goldwasser P; Antignani A; Fein PA; Mittman N ASAIO Trans; 1989; 35(3):258-60. PubMed ID: 2597459 [TBL] [Abstract][Full Text] [Related]
31. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins. Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239 [TBL] [Abstract][Full Text] [Related]
32. The impact of CAPD treatment on lipid metabolism and cardiovascular risk. Tan D; Fein PA; Antignani A; Mittman N; Avram MM Adv Perit Dial; 1990; 6():233-7. PubMed ID: 1982815 [TBL] [Abstract][Full Text] [Related]
34. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration. Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675 [TBL] [Abstract][Full Text] [Related]
35. Influence of variation at the apolipoprotein E locus on lipid and lipoprotein levels in CAPD patients. Eggertsen G; Heimbürger O; Stenvinkel P; Berglund L Nephrol Dial Transplant; 1997 Jan; 12(1):141-4. PubMed ID: 9027789 [TBL] [Abstract][Full Text] [Related]
36. Insulin resistance in dialysis versus non dialysis end stage renal disease patients without diabetes. Satirapoj B; Supasyndh O; Phantana-Angkul P; Ruangkanchanasetr P; Nata N; Chaiprasert A; Kanjanakul I; Choovichian P J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S87-93. PubMed ID: 22043573 [TBL] [Abstract][Full Text] [Related]
37. Concentration of Lp(a) and other apolipoproteins in predialysis, hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients. Kimak E; Solski J; Janicka L; Ksaziek A; Janicki K Clin Chem Lab Med; 2000 May; 38(5):421-5. PubMed ID: 10952225 [TBL] [Abstract][Full Text] [Related]
38. Initial hypoalbuminemia and hyperlipidemia persist during chronic peritoneal dialysis in children. Scolnik D; Balfe JW Perit Dial Int; 1993; 13(2):136-9. PubMed ID: 8494935 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular disease, fibrinogen and the acute phase response: associations with lipids and blood pressure in patients with chronic renal disease. Irish A Atherosclerosis; 1998 Mar; 137(1):133-9. PubMed ID: 9568745 [TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of simvastatin in hypercholesterolemic patients undergoing chronic renal dialysis. Saltissi D; Morgan C; Rigby RJ; Westhuyzen J Am J Kidney Dis; 2002 Feb; 39(2):283-90. PubMed ID: 11840368 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]